NIH-funded study finds that rituximab is as effective as standard therapy for ... News-Medical.net Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study has found. Researchers from ... |
